High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Source abstract
Abstract
Abstract The recent development of RNA‐based therapeutics in delivering nucleic acids for gene editing and regulating protein translation has led to the effective treatment of various diseases including cancer, inflammatory and genetic disorder, as well as infectious diseases. Among these, lipid nanoparticles (LNP) have emerged as a promising platform for RNA delivery and have shed light by resolving the inherent instability issues of naked RNA and thereby enhancing the therapeutic potency. These LNP consisting of ionizable lipid, helper lipid, cholesterol, and poly(ethylene glycol)‐anchored lipid can stably enclose RNA and help them release into the cells’ cytosol. Herein, the significant progress made in LNP research starting from the LNP constituents, formulation, and their diverse applications is summarized first. Moreover, the microfluidic methodologies which allow precise assembly of these newly developed constituents to achieve LNP with controllable composition and size, high encapsulation efficiency as well as scalable production are highlighted. Furthermore, a short discussion on current challenges as well as an outlook will be given on emerging approaches to resolving these issues.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · RNA and protein synthesis mechanisms · Monoclonal and Polyclonal Antibodies Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering Pohang University of Science and Technology (POSTECH) 77 Cheongam‐Ro, Nam‐Gu Pohang Gyeongbuk 37673 Korea
Funding
Korea Health Industry Development Institute · Ministry of Trade, Industry and Energy · Ministry of Science and ICT, South Korea
References (100+)
Show source-provided references
1. 10.1016/j.addr.2022.11419710.1016/j.addr.2022.114197 ↗
2. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
3. 10.1016/j.apsb.2019.08.00310.1016/j.apsb.2019.08.003 ↗
4. 10.1038/s41578-021-00398-610.1038/s41578-021-00398-6 ↗
5. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
6. 10.1038/natrevmats.2017.5610.1038/natrevmats.2017.56 ↗
7. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
8. 10.1038/s41578-021-00281-410.1038/s41578-021-00281-4 ↗
9. 10.1093/femspd/ftaa04210.1093/femspd/ftaa042 ↗
10. 10.1056/NEJMoa203538910.1056/NEJMoa2035389 ↗
11. 10.1126/science.abb250710.1126/science.abb2507 ↗
12. 10.1002/adfm.20210672710.1002/adfm.202106727 ↗
13. 10.1002/anie.20120326310.1002/anie.201203263 ↗
14. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
15. 10.1021/acsanm.0c0183410.1021/acsanm.0c01834 ↗
16. 10.1021/acs.nanolett.2c0034910.1021/acs.nanolett.2c00349 ↗
17. 10.1021/acs.macromol.1c0208610.1021/acs.macromol.1c02086 ↗
18. 10.1021/acs.chemrev.1c0024410.1021/acs.chemrev.1c00244 ↗
19. 10.1021/acs.biomac.1c0025310.1021/acs.biomac.1c00253 ↗
20. 10.1002/smtd.20170037510.1002/smtd.201700375 ↗
21. 10.1016/j.biomaterials.2021.12082610.1016/j.biomaterials.2021.120826 ↗
22. 10.1021/acs.nanolett.1c0135310.1021/acs.nanolett.1c01353 ↗
23. Tekade R. K. · 2017
24. 10.1159/00044511610.1159/000445116 ↗
25. 10.1016/j.jconrel.2015.10.00510.1016/j.jconrel.2015.10.005 ↗
26. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
27. 10.1080/17425247.2022.213550210.1080/17425247.2022.2135502 ↗
28. 10.1038/nnano.2012.16810.1038/nnano.2012.168 ↗
29. 10.1073/pnas.160029911310.1073/pnas.1600299113 ↗
30. 10.1038/s41467-020-17409-910.1038/s41467-020-17409-9 ↗
31. 10.1126/sciadv.aba506810.1126/sciadv.aba5068 ↗
32. 10.1038/emi.2013.5410.1038/emi.2013.54 ↗
33. 10.1038/mt.2014.13310.1038/mt.2014.133 ↗
34. 10.1073/pnas.86.16.607710.1073/pnas.86.16.6077 ↗
35. 10.1016/j.bbrc.2014.01.10710.1016/j.bbrc.2014.01.107 ↗
36. 10.3390/pharmaceutics1406127110.3390/pharmaceutics14061271 ↗
37. 10.1021/acsnano.1c0124310.1021/acsnano.1c01243 ↗
38. 10.1016/S0960-9776(01)80001-110.1016/S0960-9776(01)80001-1 ↗
39. 10.1016/j.jconrel.2008.10.02010.1016/j.jconrel.2008.10.020 ↗
40. 10.3390/pharmaceutics802001910.3390/pharmaceutics8020019 ↗
41. Working P. K. · Hum. Exp. Toxicol. · 1996 · 15 · 751
42. 10.1586/14760584.7.8.114110.1586/14760584.7.8.1141 ↗
43. 10.1021/jp303267y10.1021/jp303267y ↗
44. 10.1016/j.cocis.2021.10146810.1016/j.cocis.2021.101468 ↗
45. 10.1073/pnas.202040111810.1073/pnas.2020401118 ↗
46. 10.1016/j.ymthe.2019.02.01210.1016/j.ymthe.2019.02.012 ↗
47. 10.1016/j.biomaterials.2017.02.01910.1016/j.biomaterials.2017.02.019 ↗
48. 10.1002/adhm.20200093810.1002/adhm.202000938 ↗
49. 10.1002/smll.20180509710.1002/smll.201805097 ↗
50. 10.1126/science.aay363810.1126/science.aay3638 ↗
51. 10.1038/nature1830010.1038/nature18300 ↗
52. 10.1007/BF0166736310.1007/BF01667363 ↗
53. 10.1038/s41586-020-2537-910.1038/s41586-020-2537-9 ↗
54. 10.1586/14760584.6.5.78510.1586/14760584.6.5.785 ↗
55. 10.1007/s11095-016-2063-510.1007/s11095-016-2063-5 ↗
56. 10.1007/s11745-000-0578-y10.1007/s11745-000-0578-y ↗
57. 10.1016/S0021-9258(17)41980-610.1016/S0021-9258(17)41980-6 ↗
58. 10.1021/mp200662f10.1021/mp200662f ↗
59. 10.1016/j.ijpharm.2010.01.03510.1016/j.ijpharm.2010.01.035 ↗
60. 10.2147/IJN.S11536710.2147/IJN.S115367 ↗
61. Ilies M. A. · 2017
62. Shaw J. A. · 2015
63. 10.1021/bc300346h10.1021/bc300346h ↗
64. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
65. 10.1002/anie.20161020910.1002/anie.201610209 ↗
66. 10.3390/vaccines904035910.3390/vaccines9040359 ↗
67. 10.1002/adtp.20200009910.1002/adtp.202000099 ↗
68. 10.1016/j.biomaterials.2018.02.00710.1016/j.biomaterials.2018.02.007 ↗
69. 10.1248/bpb.34.133810.1248/bpb.34.1338 ↗
70. 10.1016/j.ijpharm.2020.11947910.1016/j.ijpharm.2020.119479 ↗
71. 10.1021/la500630h10.1021/la500630h ↗
72. 10.1038/s42003-021-02441-210.1038/s42003-021-02441-2 ↗
73. 10.1016/j.chemphyslip.2020.10503210.1016/j.chemphyslip.2020.105032 ↗
74. 10.1016/j.jconrel.2005.06.01410.1016/j.jconrel.2005.06.014 ↗
75. 10.1038/s41467-020-16248-y10.1038/s41467-020-16248-y ↗
76. 10.1063/5.009223710.1063/5.0092237 ↗
77. 10.1021/la020672y10.1021/la020672y ↗
78. 10.1021/acs.jpcc.0c0378510.1021/acs.jpcc.0c03785 ↗
79. 10.1016/j.bpj.2018.04.01110.1016/j.bpj.2018.04.011 ↗
80. 10.1159/00007489810.1159/000074898 ↗
81. 10.1248/cpb.c15-0007710.1248/cpb.c15-00077 ↗
82. 10.1021/acsnano.2c0477410.1021/acsnano.2c04774 ↗
83. 10.1021/mp200428d10.1021/mp200428d ↗
84. 10.1021/acsnano.7b0473410.1021/acsnano.7b04734 ↗
85. 10.1002/btm2.1021310.1002/btm2.10213 ↗
86. 10.1021/acsinfecdis.9b0008410.1021/acsinfecdis.9b00084 ↗
87. 10.1038/s41392-022-00950-y10.1038/s41392-022-00950-y ↗
88. 10.1186/s12951-022-01478-710.1186/s12951-022-01478-7 ↗
89. 10.1038/s41467-021-27493-010.1038/s41467-021-27493-0 ↗
90. 10.1039/C4TB01312C10.1039/C4TB01312C ↗
91. 10.1016/j.jconrel.2018.12.04410.1016/j.jconrel.2018.12.044 ↗
92. 10.1016/j.jconrel.2013.06.01910.1016/j.jconrel.2013.06.019 ↗
93. 10.1073/pnas.211627111910.1073/pnas.2116271119 ↗
94. S. M.Ansell X.Du U.S.A. WO201519952A1 2015.
95. 10.1016/j.omtn.2019.01.01310.1016/j.omtn.2019.01.013 ↗
96. 10.1016/j.biomaterials.2022.12164510.1016/j.biomaterials.2022.121645 ↗
97. 10.1002/adfm.20220494710.1002/adfm.202204947 ↗
98. 10.1126/sciadv.abm141810.1126/sciadv.abm1418 ↗
99. 10.1021/acsnano.2c0782210.1021/acsnano.2c07822 ↗
100. 10.1038/s41467-022-32281-510.1038/s41467-022-32281-5 ↗